To determine the requirements for Vascepa eligibility, we can refer to the provided sources [1][2][3]. Vascepa is a prescription medication that contains the active ingredient icosapent ethyl, which is used to treat certain types of high triglycerides in the blood. Here are the key eligibility requirements based on the information provided:

1. Prescription: Vascepa is a prescription medication, so you must consult a healthcare professional, such as a doctor, who can evaluate your medical condition and determine if Vascepa is appropriate for you.

2. High Triglycerides: Vascepa is specifically indicated for the treatment of very high triglyceride levels (≥500 mg/dL) in adults. Triglycerides are a type of fat found in the blood, and high levels can increase the risk of cardiovascular disease.

3. Other Treatments: Before considering Vascepa, it is important to note that lifestyle changes, such as diet and exercise, are typically recommended as the first line of treatment for high triglycerides. If these measures are not sufficient in managing triglyceride levels, then medications like Vascepa may be considered.

4. Insurance Coverage: Insurance coverage for Vascepa may vary depending on the specific insurance plan. Some insurance providers may require prior authorization before covering the medication. It is advisable to check with your insurance provider to understand the coverage details and any requirements for obtaining Vascepa.

5. Prior Authorization: The UnitedHealthcare Prior Authorization Notification for Vascepa [3] provides specific information on the prior authorization process for this medication. It outlines the clinical criteria that must be met for approval, including the specific diagnosis codes, laboratory results, and documentation requirements.

It is important to note that the information provided is a general overview based on the sources provided. The specific eligibility requirements for Vascepa may vary depending on individual circumstances, healthcare provider decisions, and insurance coverage.

Sources:
[1] Drug Patent Watch - Vascepa: https://www.drugpatentwatch.com/p/tradename/VASCEPA
[2] Vascepa Official Website: https://www.vascepa.com/
[3] UnitedHealthcare Prior Authorization Notification for Vascepa: https://www.uhcprovider.com/content/dam/provider/docs/public/prior-auth/drugs-pharmacy/commercial/r-z/PA-Notification-Vascepa.pdf